The feasibility of a dose painting procedure to treat prostate cancer based on mpMR images and hierarchical clustering

Abstract

Background We aimed to assess the feasibility of a dose painting (DP) procedure, known as simultaneous integrated boost intensity modulated radiation Therapy (SIB-IMRT), for treating prostate cancer with dominant intraprostatic lesions (DILs) based on multi-parametric magnetic resonance (mpMR) images and hierarchical clustering with a machine learning technique. Methods The mpMR images of 120 patients were used to create hierarchical clustering and draw a dendrogram. Three clusters were selected for performing agglomerative clustering. Then, the DIL acquired from the mpMR images of 20 patients were categorized into three groups to have them treated with a DP procedure being composed of three planning target volumes (PTVs) determined as PTV1, PTV2, and PTV3 in treatment plans. The DP procedure was carried out on the patients wherein a total dose of 80, 85 and 91 Gy were delivered to the PTV1, PTV2, and PTV3, respectively. Dosimetric and radiobiologic parameters [Tumor Control Probability (TCP) and Normal Tissue Complication Probability (NTCP)] of the DP procedure were compared with those of the conventional IMRT and Three-Dimensional Conformal Radiation Therapy (3DCRT) procedures carried out on another group of 20 patients. A post-treatment follow-up was also made four months after the radiotherapy procedures. Results All the dosimetric variables and the NTCPs of the organs at risks (OARs) revealed no significant difference between the DP and IMRT procedures. Regarding the TCP of three investigated PTVs, significant differences were observed between the DP versus IMRT and also DP versus 3DCRT procedures. At post-treatment follow-up, the DIL volumes and apparent diffusion coefficient (ADC) values in the DP group differed significantly (p-value < 0.001) from those of the IMRT. However, the whole prostate ADC and prostate-specific antigen (PSA) indicated no significant difference (p-value > 0.05) between the DP versus IMRT. Conclusions The results of this comprehensive clinical trial illustrated the feasibility of our DP procedure for treating prostate cancer based on mpMR images validated with acquired patients’ dosimetric and radiobiologic assessment and their follow-ups. This study confirms significant potential of the proposed DP procedure as a promising treatment planning to achieve effective dose escalation and treatment for prostate cancer. Trial registration: IRCT20181006041257N1; Iranian Registry of Clinical Trials, Registered: 23 October 2019, https://en.irct.ir/trial/34305.

The Role of Treatment-Related Parameters and Brain Morphology in the Lesion Volume of Magnetic-Resonance-Guided Focused Ultrasound Thalamotomy in Patients with Tremor-Dominant Neurological Conditions

“…Simple or multiple regression statistical analysis is not enough to represent the complexity of the multidimensional relationship between patient-related intrinsic biological characteristics and MRgFUS-related parameters (i.e., SDR, ATD, T • C_max, n • of transducer elements) in determining successful thermal ablation. The employment of more sophisticated statistical approaches (structural equation modeling, principal component analysis, machine learning, or radiomics [37,38]) is strongly suggested for future studies.…”

Integration of Ultrasound in Image-Guided Adaptive Brachytherapy in Cancer of the Uterine Cervix

“…To effectively compete with advanced radiotherapy methods that administer high levels of radiation directly to the tumour while minimising radiation exposure to nearby organs and reducing uncertainties caused by movement, brachytherapy must be performed in accordance with recommended guidelines, utilising modern imaging techniques for guidance and application [83].…”

Introducing new plan evaluation indices for prostate dose painting IMRT plans based on apparent diffusion coefficient images

“…They reported that both plans had similar TCPs; however, the dose painting had lower NTCPs. In another study by Seppala et al (59), a planning study of 12 patients was performed with DILs de ned based on 11 C acetate PET scans. Six different dose escalation plans were performed and compared for each patient, including a whole-prostate RT plan to 77.9 Gy, and DIL dose escalations to 77.9 Gy, 81 Gy, 84 Gy, 87 Gy and 90 Gy, with remaining prostate dose de-escalations to 72 Gy.…”

“…One of the strategies to improve the e ciency of radiotherapy is increasing the prescribed dose in regions with higher cancer cell densities (6). Higher doses ranging from 74 to 80 Gy has been reported to have improvements in the outcome of prostate cancer treatment (2)(3)(4)(5)(7)(8)(9)(10)(11). A meta-analysis showed that an increase in radiation dose from 70 Gy up to 80 Gy resulted in an improvement in the prostate-speci c antigen (PSA) control rates by 19% for patients with high-risk prostate cancer (12).…”